Trial on the effect of kestose on the gut microbiota of pregnant women and newborns.

Trial on the effect of kestose on the gut microbiota of pregnant women and newborns. - Trial on the effect of kestose on the gut microbiota

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000052099

Enrollment

Registered

2024-04-01

Start date

2023-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant women and their newborns

Interventions

Kestose Fructooligosaccharide

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Those who have consented to participate in the trial 2) Aged between 20 and 40 years at 3) Pregnant women with a gestational age of 26 weeks or less 4) Healthy newborns for whom stool samples can be collected

Exclusion criteria

Exclusion criteria: 1) Those with a serious chronic disease not related to pregnancy that requires medication or hospital treatment 2) Those taking probiotics/prebiotics during the study period (excluding those generally treated as food, such as yoghurt).

Design outcomes

Primary

Measure	Time frame
Composition of the gut microbiota	—

Countries

Japan

Contacts

Public ContactNaoki Shimojo

Chiba University Center for Preventive Medical Sciences

shimojo@faculty.chiba-u.jp043-290-3878

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026